Gliotaz 100mg Capsule

Gliotaz 100mg Capsule contains Temozolomide (100mg), a chemotherapy drug used primarily to treat certain brain cancers like glioblastoma multiforme and anaplastic astrocytoma. It works by damaging the DNA of cancer cells, preventing their growth and multiplication.

Uses of Gliotaz 100mg Capsule

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma
• Used alongside radiotherapy for some brain tumors

How Gliotaz 100mg Capsule works

Gliotaz is an alkylating agent that interferes with the DNA replication process in cancer cells, causing them to die and reducing tumor size.

Benefits of Gliotaz 100mg Capsule

• Helps shrink brain tumors
• Slows cancer progression
• Improves survival rates in patients
• Oral capsule for convenient use

How to take Gliotaz 100mg Capsule

Take the capsule as prescribed, usually on an empty stomach. Do not skip doses and follow the full treatment schedule.

Side effects of Gliotaz 100mg Capsule

• Nausea and vomiting
• Fatigue and weakness
• Loss of appetite
• Increased risk of infections
• Hair thinning or loss

Safety advice

• Inform your doctor about any infections before starting treatment
• Avoid contact with sick individuals during therapy
• Not recommended in pregnancy or breastfeeding without doctor approval
• Report any unusual bleeding, bruising, or infections immediately
• Regular blood tests may be required during treatment

Frequently Asked Questions (FAQs)

Q. What is Gliotaz 100mg Capsule used for?
A. It is used to treat brain tumors such as glioblastoma multiforme and anaplastic astrocytoma.

Q. How should I take Gliotaz 100mg Capsule?
A. Take it on an empty stomach as directed by your doctor.

Q. Can I skip doses if I feel better?
A. No, complete the full course as prescribed without skipping doses.

Q. What are common side effects?
A. Common side effects include nausea, fatigue, loss of appetite, and increased infection risk.

Q. Is Gliotaz safe during pregnancy?
A. It is not recommended unless your doctor advises otherwise.